|
FANCC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.916600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.96419999995723E-07 |
| Normal-vs-Stage2 |
3.620400E-01 |
| Normal-vs-Stage3 |
3.998000E-01 |
| Normal-vs-Stage4 |
8.565900E-02 |
| Stage1-vs-Stage2 |
8.187500E-02 |
| Stage1-vs-Stage3 |
2.19680000002054E-06 |
| Stage1-vs-Stage4 |
7.18849999969962E-07 |
| Stage2-vs-Stage3 |
1.633790E-01 |
| Stage2-vs-Stage4 |
5.332200E-02 |
| Stage3-vs-Stage4 |
3.741200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.388000E-02 |
| Normal-vs-AfricanAmerican |
2.771700E-02 |
| Normal-vs-Asian |
1.753760E-01 |
| Caucasian-vs-AfricanAmerican |
8.629700E-02 |
| Caucasian-vs-Asian |
1.717450E-01 |
| AfricanAmerican-vs-Asian |
9.341600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.205200E-01 |
| Normal-vs-Female |
7.23469995023152E-09 |
| Male-vs-Female |
2.51960008412766E-10 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.176000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.297760E-02 |
| Normal-vs-Age(61-80Yrs) |
1.070550E-01 |
| Normal-vs-Age(81-100Yrs) |
2.374800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.005200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.538600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.377200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.502600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.804000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.944400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.994340E-02 |
| Normal-vs-Grade 2 |
3.09119999997165E-06 |
| Normal-vs-Grade 3 |
1.644360E-01 |
| Normal-vs-Grade 4 |
5.24079999952853E-07 |
| Grade 1-vs-Grade 2 |
4.730400E-02 |
| Grade 1-vs-Grade 3 |
2.062600E-03 |
| Grade 1-vs-Grade 4 |
2.524800E-03 |
| Grade 2-vs-Grade 3 |
6.836200E-03 |
| Grade 2-vs-Grade 4 |
1.64146474190829E-12 |
| Grade 3-vs-Grade 4 |
6.88769999923622E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.985310E-04 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.481900E-03 |
| Normal-vs-N1 |
4.670800E-01 |
| N0-vs-N1 |
1.537360E-01 |
|
|
